Novel 2-substituted Dhomo-estra-1,3,5(10)-trienes as inhibitors of 17Beta-hydroxysteroid dehydrogenase type 1

Details for Australian Patent Application No. 2005259329 (hide)

International Classifications

Event Publications

1 February 2007 PCT application entered the National Phase

PCT publication WO2006/003012 Priority application(s): WO2006/003012

10 November 2011 Application Accepted

Published as AU-B-2005259329

24 November 2011 Corrigenda

Applications Accepted - Name Index Under the name Schering Aktiengesellschaft, Application No. 2005259329, under INID (71) Correct the applicant name to Bayer Schering Pharma Aktiengesellschaft

15 March 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under reg. 22.2I(2). This application has been accepted or advertised accepted. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.